“Discussion ... In conclusion, these results show the significant loss of potentially protective antibody within 6 months among elderly NH residents following BNT162b2 mRNA vaccination, particularly in those individuals without prior SARS-CoV-2 infection. Our results provide support for the current CDC policy recommending boosters in this older population, and the need for ongoing monitoring to evaluate clinical implications and inform future boosting strategies.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.